Delayed treatment with Rho-kinase inhibitor does not enhance axonal regeneration or functional recovery after spinal cord injury in rats

Experimental Neurology

Volumn 200, Issue 2, 2006, Pages 392-397

  Nishio, Yutaka ^a   Koda, Masao ^a   Kitajo, Keiko ^a   Seto, Minoru ^b   Hata, Katsuhiko ^a   Taniguchi, Junko ^a   Moriya, Hideshige ^a   Fujitani, Masashi ^a   Kubo, Takekazu ^a   Yamashita, Toshihide ^a  

^a CHIBA UNIVERSITY   (Japan)

^b ASAHI KASEI PHARMA CORPORATION   (Japan)

Author keywords

Axon; Neuron; Regeneration; Rho kinase; Spinal cord

Indexed keywords

FASUDIL; RHO KINASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CONTUSION; CONVALESCENCE; DRUG EFFICACY; HINDLIMB; LOCOMOTION; MALE; NERVE FIBER REGENERATION; NERVE SPROUTING; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY; THERAPY DELAY; THORACIC SPINAL CORD;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ANIMALS; BEHAVIOR, ANIMAL; BIOTIN; DEXTRANS; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; ENZYME INHIBITORS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MOTOR ACTIVITY; NERVE REGENERATION; PROTEIN-SERINE-THREONINE KINASES; PYRAMIDAL TRACTS; RATS; RATS, WISTAR; RECOVERY OF FUNCTION; SPINAL CORD INJURIES; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 33746286637     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2006.02.123     Document Type: Article

References (19)

1. Amano M., Fukata Y., and Kaibuchi K. Regulation and functions of Rho-associated kinase. Exp. Cell Res. 261 (2000) 44-51
2. Basso D.M., Beattie M.S., and Bresnahan J.C. A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 12 (1995) 1-21
3. Chan C.C., Khodarahmi K., Liu J., Sutherland D., Oschipok L.W., Steeves J.D., and Tetzlaff W. Dose-dependent beneficial and detrimental effects of ROCK inhibitor Y27632 on axonal sprouting and functional recovery after rat spinal cord injury. Exp. Neurol. 196 (2005) 352-364
4. Dergham P., Ellezam B., Essagian C., AvedIissian H., Lubell W.D., and McKerracher L. Rho signaling pathway targeted to promote spinal cord repair. J. Neurosci. 22 (2002) 6570-6577
5. Dickson B.J. Rho GTPases in growth cone guidance. Curr. Opin. Neurobiol. 11 (2001) 103-110
6. Dubreuil C.I., Winton M.J., and McKerracher L. Rho activation patterns after spinal cord injury and the role of activated Rho in apoptosis in the central nervous system. J. Cell Biol. 162 (2003) 233-243
7. Dumont R.J., Verma S., Okonkwo D.O., Hurlbert R.J., Boulos P.T., Ellegala D.B., and Dumont A.S. Acute spinal cord injury: Part II. Contemporary pharmacotherapy. Clin. Neuropharmacol. 24 (2001) 265-279
8. Fournier A.E., and Takizawa B.T. Rho kinase inhibition enhances axonal regeneration in the injured CNS. J. Neurosci. 23 (2003) 1416-1423
9. Hara M., Takayasu M., Watanabe K., Noda A., Takagi T., Suzuki Y., and Yoshida J. Protein kinase inhibition by fasudil hydrochloride promotes neurological recovery after spinal cord injury in rats. J. Neurosurg. 93 (2000) 94-101
10. Madura T., Yamashita T., Kubo T., Fujitani M., Hosokawa K., and Tohyama M. Activation of Rho in the injured axons following spinal cord injury. EMBO Rep. 5 (2004) 412-417
11. McKerracher L., and Winton M.J. Nogo on the go. Neuron 36 (2002) 345-348
12. Monnier P.P., Sierra A., Schwab J.M., Henke-Fahle S., and Mueller B.K. The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar. Mol. Cell. Neurosci. 22 (2003) 319-330
13. Mueller B.K., Mack H., and Teusch N. Rho kinase, a promising drug target for neurological disorders. Nat. Rev., Drug Discov. 4 (2005) 387-398
14. Shibuya M., Suzuki Y., Sugita K., Saito I., Sasaki T., Takakura K., Nagata I., Kikuchi H., Takemae T., Hidaka H., et al. Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial. J. Neurosurg. 76 (1992) 571-577
15. Shimokawa H., Hiramori K., Iinuma H., Hosoda S., Kishida H., Osada H., Katagiri T., Yamauchi K., Yui Y., Minamino T., Nakashima M., and Kato K. Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study. J. Cardiovasc. Pharmacol. 40 (2002) 751-761
16. Sung J.K., Miao L., Calvert J.W., Huang L., Louis Harkey H., and Zhang J.H. A possible role of RhoA/Rho-kinase in experimental spinal cord injury in rat. Brain Res. 959 (2003) 29-38
17. Tanaka H., Yamashita T., Yachi K., Fujiwara T., Yoshikawa H., and Tohyama M. Cytoplasmic p21(Cip1/WAF1) enhances axonal regeneration and functional recovery after spinal cord injury in rats. Neuroscience 127 (2004) 155-164
18. Yamashita T., Higuchi H., and Tohyama M. The p75 receptor transduces the signal from myelin-associated glycoprotein to Rho. J. Cell Biol. 157 (2002) 565-570
19. Young W. Spinal cord regeneration. Science 273 (1996) 450-451